Takeda Pharmaceutical Co Ltd (NYSE:TAK)
| 13.35 Delayed Data As of Nov 30 |  -0.14 / -1.04%Today’s Change | 13.20 Today|||52-Week Range 19.97 | -26.65% Year-to-Date |
Latest TAK News | Press Releases
| 2 Ultra-High-Yield Dividend Stocks to Buy as a Hedge Against Inflation Nov 30 / MotleyFool.com - Paid Partner Content | Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval Nov 25 / Zacks.com - Paid Partner Content |
| Take Advantage of the Market’s Dip and Buy These 5 Cheap Value Stocks Nov 30 / StockNews.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.49 |
| Today’s open | 13.42 |
| Day’s range | 13.20 - 13.42 |
| Volume | 13,285 |
| Average volume (3 months) | 2,242,397 |
| Market cap | $42.6B |
Data as of 4:00pm ET, 11/30/2021
Growth & Valuation
| Earnings growth (last year) | +768.32% |
| Earnings growth (this year) | -41.73% |
| Earnings growth (next 5 years) | +10.50% |
| Revenue growth (last year) | -0.39% |
| P/E ratio | 10.1 |
| Price/Sales | 1.91 |
| Price/Book | 0.90 |
Competitors
Data as of 4:41pm ET, 11/30/2021
Financials
| Next reporting date | February 3, 2022 |
| EPS forecast (this quarter) | $0.16 |
| Annual revenue (last year) | $30.2B |
| Annual profit (last year) | $3.5B |
| Net profit margin | 11.76% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Osaka, Osaka |
Forecasts
